Amiodarone Treatment Ups Cancer Risk in Males

This article originally appeared here.
Share this content:
Amiodarone Treatment Is Linked to Higher Cancer Risk
Amiodarone Treatment Is Linked to Higher Cancer Risk

(HealthDay News) -- Amiodarone treatment for arrhythmias is associated with a higher risk of developing cancer, particularly in males and with increasing dose, according to a study published online April 8 in Cancer.

Noting that the U.S. Food and Drug Administration has reported that cancer can develop after amiodarone treatment, Vincent Yi-Fong Su, M.D., from Taipei Veterans General Hospital in Taiwan, and colleagues retrospectively compared the risk of cancer in 6,418 patients (3,674 males and 2,744 females) in Taiwan who were treated with amiodarone from 1997 to 2008 with that of the general population.

After a median follow-up of 2.57 years, the researchers found 280 cases of cancer. The risk of cancer was higher after amiodarone treatment (standardized incidence ratio [SIR] 1.12; P = .067), especially among male patients (SIR 1.18; P = .022), but the results were of borderline significance. Among patients with a cumulative defined daily dose (CDDD) greater than 180 within the first year, the SIR was 1.28 overall (P = .046), but was 1.46 (P = .008) among male patients. After adjusting for age, sex, and comorbidities, the hazard ratio for the highest tertile of CDDD compared with the lowest was 1.98 (P = .006), according to the study.

"The results of the current study indicate that amiodarone may be associated with an increased risk of incident cancer, especially in males, with a dose-dependent effect," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs